ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
äŒæ¥ã³ãŒãASPI
äŒç€ŸåASP Isotopes Inc
äžå Žæ¥Nov 10, 2022
æé«çµå¶è²¬ä»»è
ãCEOãAinscow (Robert)
åŸæ¥å¡æ°136
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Nov 10
æ¬ç€Ÿæåšå°601 Pennsylvania Avenue Nw
éœåžWASHINGTON
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·20004
é»è©±çªå·12027562245
ãŠã§ããµã€ãhttps://aspisotopes.com/
äŒæ¥ã³ãŒãASPI
äžå Žæ¥Nov 10, 2022
æé«çµå¶è²¬ä»»è
ãCEOãAinscow (Robert)